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ABSTRACT
Many techniques for flap monitoring following free tissue transfer have been
described; however, there is little evidence that any of these techniques allow for greater
rates of flap salvage over clinical monitoring alone. We sought to compare three established
monitoring techniques across three experienced microsurgical centers in a comparable
cohort of patients. A retrospective, matched cohort study of 398 consecutive free flaps in
347 patients undergoing autologous breast reconstruction was undertaken across three
institutions during the same 3-year period, with a single form of postoperative monitoring
used at each institution: clinical monitoring alone, the Cook-Swartz implantable Doppler
probe, or microdialysis. Both objective and subjective measures of efficacy were assessed.
Clinical monitoring alone, the implantable Doppler probe, and microdialysis showed
statistically similar rates of flap salvage. False-negative rates were also statistically similar
(only seen in the clinically monitored group). However, there was a statistically significant
increase in false-positive alarms causing needless take-backs to theater in the microdialysis
and implantable Doppler arms, p< 0.001. This study did not find any technique superior to
clinical monitoring alone. New monitoring technologies should be compared objectively
with clinical monitoring as the current standard in postoperative flap monitoring.
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Microsurgical free tissue transfer is widely used
internationally, and many authors now consider fascio-
cutaneous flaps such as the deep inferior epigastric artery
flap to be the gold standard in breast reconstruction.
Increased experience with these procedures and advances
in preoperative planning have potentiated published flap
loss rates of lower than 2%.1–5 Preoperative assessment
of flap vasculature has been shown to be useful in
improving surgical outcomes and flap selection,6 and
the intraoperative evaluation of vascular pedicles has
allowed for greater confidence in the viability of large
free flaps.7,8
Despite these advances, there is a low but sig-
nificant risk with any such operation that arterial or
venous compromise may occur, which will warrant a
revision of the microsurgical anastomoses. With the
potential for either flap salvage or flap loss, prompt and
effective postoperative evaluation of flap viability is
essential, and may potentiate early intervention.
Whereas the no-reflow phenomenon will still mean
that flaps are lost regardless of the microsurgeon’s
experience, optimal methods for postoperative monitor-
ing of free flaps are being increasingly sought.
A broad range of different technologies have been
discussed for postoperative monitoring, but few studies
use a relevant clinical outcome as the primary endpoint
of the trial, and as such there is little evidence for any
single technique. This is reflected in the wide variety of
techniques currently used in this role: clinical monitoring
alone, pulse oximetry, near infrared spectroscopy, perfu-
sion photoplethysmography, surface temperature meas-
urement, fluorometry, microdialysis, ultrasound, the
hand-held Doppler probe, implanted (Cook-Swartz)
Doppler probes, laser Doppler flowmetry, impedance
plethysmography, confocal microscopy, nuclear medi-
cine, subcutaneous pH measurement, hydrogen clear-
ance, externalization of part of a buried flap, and white
light spectrometry. Surveys of plastic surgical units
across the United Kingdom showed that there is sub-
stantial variation in the methods, organization, and
implementation of monitoring techniques following
free tissue transfer.9–11
The need for the earliest possible detection of free
flap compromise has been widely shown to be an
essential element in salvage, with the no-reflow phe-
nomenon, first described in 1978,12 showing that flap
salvage was closely related to ischemic time. Recent
publications confirm that flap survival is dependent on
ischemic time,3,13–16 reiterating the need for optimal
methods for postoperative monitoring. Creech and
Miller in 197517 outlined the essential criteria for free
flap monitoring:
! Simple and harmless to the patient and flap;
! Rapid, repeatable, reliable, recordable, and rapidly
responsive;
! Accurate and inexpensive;
! Objective and applicable to all kinds of flaps; and
! Equipped with simple displays that could alert rela-
tively inexperienced personnel.
Although operating techniques have changed
since these criteria were first devised, they still aptly
describe the issues that prospective monitoring techni-
ques must address.
As yet, there is no proven method that satisfies
all of these criteria, and thus surgeons currently
choose techniques based on cost, availability, and
the method that satisfies their priorities in postoper-
ative care. A recent single surgeon cohort study
comparing the implantable Doppler probe with clin-
ical assessment demonstrated an improvement in out-
come measures with the implantable Doppler probe,18
and we sought to further this analysis by comparing
the use of three established monitoring techniques
across three experienced microsurgical centers in a
recent and comparable cohort of patients. Thus, this
study, using the three different techniques (the im-
plantable Cook-Swartz Doppler probe, microdialysis,
and clinical monitoring alone) as the primary
mode for postoperative monitoring, was designed.
All these techniques have been previously shown to
accurately predict the onset and existence of flap
compromise.
METHODS
Study Design
A retrospective, matched cohort study of 398 consec-
utive free flaps in 347 patients undergoing autologous
breast reconstruction was undertaken across three insti-
tutions during the same 3-year period, with a single form
of postoperative monitoring used at each institution.
Only fasciocutaneous flaps (per the Mathes and Nahai
classification19) for breast reconstruction were included,
all of which were suitable for monitoring with each of
the techniques assessed. These comprised deep inferior
epigastric artery perforator flaps (Types B and C fascio-
cutaneous flaps), superficial inferior epigastric artery
flaps (Type A fasciocutaneous flaps), and superior gluteal
artery perforator flaps (Type C fasciocutaneous flaps)
(see Table 1). No buried flaps were included in the series.
Of the 398 flaps monitored, 235 were monitored with
clinical assessment only (Fig. 1), 121 were monitored
with the Cook-Swartz implantable Doppler probe
(Cook Medical, Cook Ireland Ltd, Limerick, Ireland)
(Fig. 2), and 42 were monitored with microdialysis
(CMA-Microdialysis AB, Solna, Sweden) (Fig. 3).
Institutional ethical approval was obtained, with each
patient consenting to the use of each monitoring
technique.
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Each monitoring technique was applied according
to criteria dictated by the individual unit, with no
required standard in technique. Clinical monitoring
was achieved through the assessment of the color,
temperature, tactility, capillary refill, bleeding, and ap-
pearance of the flap. The Cook-Swartz probe silicone
cuff was applied to the venous pedicle following suc-
cessful venous anastomosis (per manufacturer and liter-
ature specifications). Application was always distal to the
anastomosis, and microclips were used for attachment.
The probe was left in situ for at least 1 week during the
monitoring period and then removed. Microdialysis
probes were applied to varying regions of the flap based
on surgeon preference, with lactate, glucose, glycerol,
and pyruvate measured.
A comparison between the three techniques for
postoperative monitoring was performed. This included
a comparison of demographic data, rates for return to
theater (take-back rates), the salvage rates for those flaps
returned to theater, and ultimate flap outcome in all
cases. Of note, there were no logistical or other delays in
returning to theater in any of the groups once the
decision to return to theater had been made.
Data Analysis
The data were presented quantitatively, with all out-
comes and the need to take-back recorded per flap, and
the salvage rates recorded as the ultimate clinical out-
come per flap. Each flap being monitored was recorded
as either encountering a positive monitoring alarm or not
encountering an alarm, with findings at theater noted
Table 1 Patient Demographics Comparing the Three Monitoring Technique Groups
Patient Demographics
Clinical
Assessment
Cook-Swartz
Implantable Doppler Probe Microdialysis
Number of patients 202 103 42
Number of breast reconstructions 235 121 42
Sex (% female) 100 100 100
Number of DIEP flaps 225 106 42
Number of SIEA flaps 10 15 0
Number of SGAP flaps 0 4 0
DIEP, deep inferior epigastric artery perforator; SGAP, superior gluteal artery perforator; SIEA, superficial inferior epigastric artery.
Figure 1 Immediate postoperative photograph of a deep
inferior epigastric artery perforator (DIEP) flap being moni-
tored with clinical monitoring alone.
Figure 2 Immediate postoperative photograph of a deep
inferior epigastric artery perforator (DIEP) flap being moni-
tored with the Cook-Swartz implantable Doppler probe.
Figure 3 Photograph of a deep inferior epigastric artery
perforator (DIEP) flap being monitored with microdialysis.
The photograph is taken at the end of a reexploration
performed on the third postoperative day based on micro-
dialysis values.
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and recorded in a flow chart (Fig. 4). True-positives
comprised flaps in which positive monitoring alarms
were found to have true pedicle compromise, false-
positives comprised flaps in which positive monitoring
alarms were found to have no pedicle compromise, true-
negatives comprised flaps in which there were no alarms
and flaps survived, and false-negatives comprised flaps in
which there were no alarms but flaps ultimately failed.
Outcome Measures
The primary outcome measure in comparing techniques
comprised ‘‘objective’’ assessments of monitoring effi-
cacy, as previously outlined by Whitney et al and
Lineaweaver.20,21 Unlike other diagnostic tests, in which
sensitivity and specificity are the most useful measures of
efficacy, monitoring is ‘‘time dependent,’’ in that all
monitoring tests will eventually show a positive result;
however, it is the time course to this result that affects
free flap outcomes. As such, the ‘‘flap salvage rate’’ for
flaps returned to theater (with early intervention result-
ing in flap salvage) and the false-positive rate (the
limitation of a given technique being unnecessary returns
to theater) are the two most important measures of
efficacy. Of note, these calculations are true measures
of efficacy because they are independent of surgeon
decision making.
A secondary outcome measure comprised the
false-negative rate, which although theoretically may
be a measure of monitoring efficacy, is dependent on
surgeon decision making because the decision to take a
flap to theater for revision changes this measure (a failing
flap could be categorized as either true-positive if taken
back to theater or false-negative if not taken back).
Decisions such as this should clearly not influence an
objective measure of monitoring efficacy, and thus such
cases are more accurately represented by reducing the
flap salvage rate of the given monitoring technique.
Finally, the qualitative (subjective) benefits of the use
of each monitoring technique were evaluated.
The flap salvage rate was calculated as a quotient
of all flaps with true pedicle compromise that ultimately
survived and all flaps with true pedicle compromise
(all true-positives and all false-negatives). The false-
positive rate was calculated as a quotient of all flaps with
positive monitoring alarms that were found to have no
pedicle compromise (false-positives) and all flaps with
no pedicle compromise (all false-positives and all true-
negatives). The false-negative rate was calculated as a
quotient of all flaps without monitoring alarms that
were found to have pedicle compromise (false-nega-
tives) and all flaps with pedicle compromise (all false-
negatives and all true-positives).
Data for each monitoring group were analyzed for
statistical significance performed using the Fisher exact
test. Statistical significance was considered at p" 0.05.
RESULTS
The three groups analyzed were comparable in terms of
patient cohort and operative technique (Table 1).
Although there were differences between institutions
in patient volume and experience with breast reconstruc-
tion, all institutions were experienced microsurgical
centers with significant experience in a range of micro-
surgical procedures.
There were 28 flaps in the series that required
take-back to theater on the basis of positive monitoring
Figure 4 Flow chart for the recording of outcomes for each flap monitored, with each flap being recorded as either
encountering a positive monitoring alarm or not encountering an alarm, with findings at theater noted, and ultimate outcomes
recorded for each group.
412 JOURNAL OF RECONSTRUCTIVE MICROSURGERY/VOLUME 26, NUMBER 6 2010
test findings. Of the eight such cases that were moni-
tored clinically (Fig. 5), two did not return to theater
before there was evidence of flap necrosis (false-
negatives), whereas six returned for venous compromise
and were all salvaged. Of the 11 cases monitored with
the implantable Doppler probe, 8 were revised and
salvaged, 2 were unsalvageable, and 1 was a false-positive
monitoring alarm. Of the nine cases monitored with
microdialysis, five were salvaged, one failed, and three
were false-positive alarms, with only territorial issues
identified.
In terms of the primary outcome measure, there
were statistically significant differences between the
groups (Table 2). There was no significant difference
in salvage rates between the three groups, with high
salvage rates in all groups (range 75 to 83%, p¼ 0.93).
However, a significant difference was found between
groups in terms of false-positive rates: with no false-
positives in the clinically monitored group (0%), 0.9%
false-positives in the implantable Doppler group, and
8.1% false-positives in the microdialysis group
(p< 0.001). In these cases, a patent flowing pedicle
was identified upon return to the theater, but territorial
congestion was noted.
In terms of the secondary outcome measure, there
was no statistically significant difference between groups
for the false-negative rate (see Table 2). In the clinically
monitored group, there were two false-negatives but no
flaps that failed after reexploration; on the other hand,
there were no false-negatives in the other two groups but
there were failed flaps following reexploration. As men-
tioned, the decision to reexplore a flap is based upon
individual surgeon preference, and is not a true test of
the monitoring technique because a ‘‘false-negative’’ may
be equivalent to a ‘‘true-positive, unsalvageable flap,’’ if
the decision to reexplore is not made.
The third outcome measure, the secondary meas-
ure of qualitative assessment in the use of these techni-
Table 2 Primary Outcome Measures 1 and 2: Quantitative Assessment of the Efficacy of each Monitoring Technique
by Primary Outcome Measure 1, Flap Salvage Rate, and False-Positive Rate, and Primary Outcome Measure 2, Timing
of Flap Loss – Flap Loss Rate after Attempted Salvage, and the Rate of Missed Flap Losses (the False-Negative Rate)
Clinical
Assessment
Cook-Swartz
Implantable
Doppler Probe Microdialysis p Value
Primary Outcome Measures
Flap salvage rate (salvaged flaps/
compromised flaps) (n, %)
6/8¼75% 8/10¼ 80% 5/6¼ 83% 0.93
False-positive rate (false-positives/
uncompromised flaps) (n, %)
0/227¼ 0% 1/111¼0.9% 3/37¼8.1% <0.001
Secondary Outcome Measure
False-negative rate (false-negatives/
compromised flaps) (n, %)
2/8¼25% 0/10¼ 0% 0/6¼ 0% 0.11
Figure 5 Flow chart for the recording of outcomes for each flap monitored. CM, clinical monitoring; IDP, implantable Doppler
probe; MD, microdialysis.
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ques, demonstrated each technique to have positive and
negative attributes. The particular benefits of clinical
monitoring are cost and the ability to readily distinguish
territorial compromise, whereas the implantable Dop-
pler probe and microdialysis improve patient comfort
during assessment and provide an objective monitor.
The implantable Doppler probe uniquely avoids any
physiologic or sampling delay in diagnosis by providing
an instantaneous measure of pedicle flow.
DISCUSSION
The results of this study demonstrate both the utility and
pitfalls of each different monitoring technique in the
postoperative monitoring of free flaps. This study dem-
onstrated that the use of microdialysis and the implant-
able Doppler significantly increases the rate of
unnecessary take-backs to theater (the false-positive
rate) over the use of clinical monitoring alone. This is
in the context of both the implantable Doppler probe
and microdialysis not significantly improving the salvage
rate of free flaps or false-negative rate (although false-
negatives were eliminated in these groups). Both benefits
and pitfalls of each of the techniques evaluated were
identified, and the evaluation of objective outcomes
showed that neither adjunctive technique was superior
to clinical monitoring alone.
Implantable Doppler Probe
The implantable Doppler probe manufactured by Cook
has gained recent attention in the plastic surgery
literature.5,22–30 The first attempts to utilize an im-
plantable Doppler probe for free flap monitoring was in
1984, by Parker et al,29 and soon thereafter the Cook-
Swartz probe was developed in 1988 specifically for use
in free flap operations.30 It was initially used on the
arterial pedicle, but subsequent studies showed it to be
more sensitive when placed on the venous anastomosis,
particularly for the detection of venous thrombosis.23 A
study by Kind et al27 of 135 free flap operations in 1998
showed that the Cook-Swartz probe produced a high
false-positive rate (20% of positive results, with a 2.9%
false-positive rate as calculated by our method) and
no false-negative results. All of the 16 compromised
flaps were salvaged. The use of the probe was well
received by all junior and senior medical staff and
nursing staff. Results similar to those of Kind et al
were seen in a separate analysis of the Cook-Swartz arm
of our study.25 The Cook-Swartz probe does have a
small false-positive rate,25,27 and initial studies were
associated with a low rate of probe malfunction, which
was thought to be due to a learning curve for surgeons
in applying the probe23,29,30 (problems pertaining par-
ticularly to probe placement). Rosenberg et al31 found a
high false-positive rate of 88%, which was actually 37%
as calculated by our method, but no other trial has
replicated a false-positive rate as high as this. It is
difficult to ascertain why this result was so much higher
than other reported rates, but the learning curve could
play a part because only 20 cases of implanted Doppler
monitoring were presented. These results by Rosenberg
et al also applied to a diverse range of flap types and
recipient sites making interpretation difficult. A recent
large cohort study demonstrated an improvement in
flap salvage rate with the Cook-Swartz probe over
clinical monitoring alone, and a meta-analysis of the
literature confirmed the statistically significant benefit
of the Cook-Swartz probe over clinical monitoring.18
Microdialysis
This technique was first described in the setting of free
flap monitoring by Udesen et al,32 who described the use
of a double lumen catheter with a semipermeable mem-
brane at the end. This catheter is placed within the flap
to be monitored (see Fig. 3), and a small amount of fluid
is pumped through the catheter. As this fluid passes
through a semipermeable membrane, small molecules
pass into the dialysate, which are then analyzed. The
levels of certain metabolites within the transferred tissue
are used to ascertain the metabolic state of that tissue.
There are many molecules capable of being assessed with
microdialysis, with typical metabolites comprising lac-
tate, glucose, glycerol, and pyruvate.32–35 Udesen et al
used a similar catheter placed elsewhere in the body for a
reference comparison, whereas some later studies have
simply compared results with reference values or used
increasing lactate:pyruvate ratios as a measure of ische-
mia. Authors have generally agreed that microdialysis
provides a timely and sensitive indication of flap ische-
mia. Studies comparing different flaps and regions
within flaps have shown significant differences in micro-
dialysis results,33 an illustration of the sensitivity of this
technique. Sorensen35 successfully used microdialysis in
buried free jejunal transfers to identify early flap com-
promise, salvaging two such transfers. Jyra¨nki et al34
reported a case series of free flaps monitored with
microdialysis, and reported two cases in which metabolic
change occurred before clinical signs; however, both
flaps were unsalvageable upon reexploration.
The mechanisms of action of each technique
assessed in this study may explain our findings. The
implantable Doppler probe measures and records flow
within the vascular pedicle, and is thus an immediate
reflection of impaired flow.23,28 This occurs before
clinical signs of ischemia become evident, and possibly
earlier than the measurable biochemical markers of
ischemia change. Microdialysis requires the biochemical
markers of ischemia to rise, and requires a time delay
(albeit small) for collection, testing, and the representa-
tion of results in graphical form. Clinical assessment can
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demonstrate early changes in perfusion that may reflect
flap ischemia; however, this occurs some time after flow
is noted to be reduced on Cook-Swartz Doppler mon-
itoring.23 As such, there are intuitive benefits of the
implantable Doppler probe over microdialysis, broadly
categorized as physiologic error and sampling error.
Physiologically, the Doppler probe can identify impaired
pedicle flow substantially earlier in the course of venous
compromise than the measurable effects of tissue ne-
crosis as with microdialysis. In terms of sampling error,
the implanted Doppler probe provides a continuous
measurement of pedicle flow (although in practice it is
often tested intermittently), compared with the static
evaluation with clinical assessment (as it is usually
performed) and microdialysis, at given points in time.
This error is compounded with microdialysis because
there is an ‘‘analysis’’ period even after the sample has
been collected. These factors are all contributors to a
reduction in the time to detection of flap ischemia,
extending the time between ischemic onset and reexplo-
ration, which is known to be a key factor in the salvage
rate for free flaps.3,12–16
Although we have assessed these techniques on
‘‘objective’’ clinical criteria, in which we have explained
the benefit of flap salvage rate and false-positive rate as
the most objective, monitoring methods are not nec-
essarily to be judged on a single set of clinical criteria
alone. Other factors, such as ease of use, patient
comfort, and cost come into play. In addition, the
ability of clinical monitoring to distinguish between
‘‘territorial’’ compromise and ‘‘obstructive’’ compro-
mise is a key factor in minimizing false-positives,
and selecting those cases for which any intervention
is appropriate.
The current trial does not identify either adjunc-
tive method as producing a better clinical outcome when
compared with subjective clinical monitoring alone. In
fact, comparisons of large studies using different mon-
itoring techniques have revealed similar flap success rates
(98 to 99%) and salvage rates (up to 80%), regardless of
the monitoring system used.1–5 In our study, we com-
pared the techniques as stand-alone measures; however,
an additional use for objective monitoring techniques is
as an adjunct to clinical monitoring, providing added
reassurance to clinical assessment and potentially im-
proving outcome measures. When used as stand-alone
measures, the implantable Doppler probe and micro-
dialysis are capable of being used without the need to
wake the patient, and thus avoid the sleep deprivation of
half-hourly flap observations.
A unique group of microvascular transfers are
more difficult to assess and thus have lower salvage
rates.3 This group of ‘‘buried’’ free flaps cannot be easily
monitored clinically, and several authors have advocated
the use of adjunctive monitoring techniques in such
flaps.1 It is in this group that the results of this study
and those of the future studies on advanced monitoring
techniques will become particularly applicable.
CONCLUSION
Many objective and subjective techniques for flap mon-
itoring have been described to monitor free tissue trans-
fers,36 and despite significant research efforts, there has
been little evidence that any of these techniques allow for
greater rates of flap salvage over clinical monitoring
alone. This study has shown that in the participating
three international units, clinical monitoring alone, the
Cook-Swartz implantable Doppler probe, and micro-
dialysis showed statistically similar rates of flap salvage
and false-negative rates (only seen in the clinical group).
However, there was a statistically significant increase in
false-positive alarms causing needless take-backs to
theater in the microdialysis and implantable Doppler
arms, p< 0.001. This study, thus, did not show any
technique to be better than clinical monitoring alone.
Future monitoring studies with clinically relevant results
are advised, rather than just the publication of uncon-
trolled data with a single method.
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